COVID-19 Vaccine Hesitancy An Opening For New Trial, US FDA’s Califf Says In Farewell

 
• By Michael McCaughan

In his final days as commissioner, Robert Califf posted thoughts on the COVID-19 vaccine experience and the limited booster uptake, suggesting that a placebo-controlled trial of the next booster update be run to improve confidence and develop better evidence in subgroups.

Califf wrote that a new CBER analysis confirmed the benefit of the COVID-19 vaccine and boosters. (Shutterstock)
Michael McCaughan

Read more by Michael McCaughan

Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He was previously the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication.

More from Vaccines

More from R&D